BioAtla, Inc.
Developing safer, conditionally active antibody therapies for solid tumor cancers.
BCAB | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 11085 TORREYANA ROAD, 92121 SAN DIEGO
- Website:
- https://www.bioatla.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
BioAtla, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel antibody-based therapeutics for treating solid tumor cancers. The company's core technology is its proprietary Conditionally Active Biologics (CAB) platform. This platform engineers antibodies and other biologics to be activated or inactivated under specific physiological conditions, such as those found in the tumor microenvironment. The primary objective of the CAB technology is to develop safer and more effective cancer treatments by creating therapies with an improved therapeutic index, enhancing efficacy against tumors while minimizing damage to healthy tissue.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all BioAtla, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioAtla, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioAtla, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
